BIOLASE (BIOL) stock Forecast for 2022 – 2026
Last update: 05-20-2022, 9:29Sector: Healthcare
The share price of BIOLASE, Inc. (BIOL) now
What analysts predict:: $36.67
52-week high/low: $23.48 / $3.3
50/200 Day Moving Average: $7.36 / $11.57
This figure corresponds to the average price over the previous 50/200 days. For BIOLASE stocks, the 50-day moving average is the resistance level today.
For BIOLASE stocks, the 200-day moving average is the resistance level today.
Are you interested in BIOLASE, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the BIOLASE stock price in 2022, 2023, 2024, 2025, 2026. How much will one BIOLASE share be worth in 2022 - 2026?
When should I take profit in BIOLASE stock? When should I record a loss on BIOLASE stock? What are analysts' forecasts for BIOLASE stock? What is the future of BIOLASE stock?
We forecast BIOLASE stock performance using neural networks based on historical data on BIOLASE stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
BIOLASE stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for BIOLASE shares. This happens once a day.
Historical and forecast chart of BIOLASE stock
The chart below shows the historical price of BIOLASE stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BIOLASE stock price can be found in the table below.
Long-term forecasts by years.
BIOLASE daily forecast for a month
BIOLASE Daily Price Targets
BIOLASE Stock Forecast 05-22-2022.
Pessimistic target level: 3.89
Optimistic target level: 3.99
BIOLASE Stock Forecast 05-23-2022.
Pessimistic target level: 3.93
Optimistic target level: 4.02
BIOLASE Stock Forecast 05-24-2022.
Pessimistic target level: 3.86
Optimistic target level: 4.00
BIOLASE Stock Forecast 05-25-2022.
Pessimistic target level: 3.76
Optimistic target level: 3.99
BIOLASE Stock Forecast 05-26-2022.
Pessimistic target level: 3.97
Optimistic target level: 4.14
BIOLASE Stock Forecast 05-27-2022.
Pessimistic target level: 3.94
Optimistic target level: 4.03
BIOL (BIOL) Monthly Stock Prediction for 2022
BIOLASE forecast for this year
BIOLASE Stock Prediction for Jun 2022
An uptrend is forecast for this month with an optimal target price of $4.20706. Pessimistic: $3.66. Optimistic: $4.44
BIOLASE Stock Prediction for Jul 2022
An uptrend is forecast for this month with an optimal target price of $4.74346. Pessimistic: $4.57. Optimistic: $4.96
BIOLASE Stock Prediction for Aug 2022
An uptrend is forecast for this month with an optimal target price of $4.87248. Pessimistic: $4.24. Optimistic: $5.31
BIOLASE Stock Prediction for Sep 2022
An downtrend is forecast for this month with an optimal target price of $4.52458. Pessimistic: $4.22. Optimistic: $5.10
BIOLASE Stock Prediction for Oct 2022
An uptrend is forecast for this month with an optimal target price of $4.87071. Pessimistic: $4.68. Optimistic: $5.09
BIOLASE Stock Prediction for Nov 2022
An uptrend is forecast for this month with an optimal target price of $5.15224. Pessimistic: $4.85. Optimistic: $5.70
BIOLASE Stock Prediction for Dec 2022
An uptrend is forecast for this month with an optimal target price of $5.18728. Pessimistic: $4.59. Optimistic: $5.44
BIOLASE (BIOL) Monthly Stock Prediction for 2023
BIOLASE (BIOL) Monthly Stock Prediction for 2024
BIOLASE (BIOL) Monthly Stock Prediction for 2025
BIOLASE (BIOL) Monthly Stock Prediction for 2026
BIOLASE information and performance
BIOLASE, Inc. is a medical device company, which engages in developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems uses a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Lake Forest, CA.
4 CROMWELL, IRVINE, CA, US
Market Capitalization: 24 633 600 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: -15 074 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: -0.22
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.456
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 0.169
Enterprise Value (EV) /Revenue
EV To EBITDA: -
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 6173800
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
BIOLASE (BIOL) stock dividend
BIOLASE last paid dividends on 06/24/2005. The next scheduled payment will be on 05/11/2018. The amount of dividends is $0 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Factor:
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.